ORANGEBURG, N.Y., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the second quarter fiscal 2015, ended September 30, 2014, after the market closes on Wednesday, November 5, 2014. Howard Zauberman, President and Chief Executive Officer, and Gary Siegel, Vice President, Finance, will host a conference call to discuss the results as follows:
|Date:||Thursday, November 6, 2014|
|Time:||8:30 a.m. EST|
|Conference dial-in:||(877) 303-1595 U.S.|
|(970) 315-0449 International|
An audio replay of the conference call will be available from 11:30 a.m. EST on Thursday, November 6, 2014, through 11:59 p.m. EST on Thursday, November 13, 2014, by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from abroad. The audio webcast will also be available in the investor section of the Company's website, www.visionsciences.com.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.
Vision-Sciences owns the registered trademarks Vision Sciences®, EndoSheath®, EndoWipe®, Slide-On®, and The Vision System®.